Zentalis Pharmaceuticals

Filed a patent for "tricyclic compounds" on Wed, January 18, 2023

Filed a patent for "immunoconjugates and methods" on Wed, January 25, 2023

Filed a patent for "homologous recombination repair deficiency (hrd) as a predictive biomarker for treating cancer with wee1 inhibitors" on Fri, June 2, 2023

Filed a patent for "homologous recombination repair deficiency (hrd) as a predictive biomarker for treating cancer with wee1 inhibitors" on Wed, November 15, 2023

Filed a patent for "wee1 inhibitors and methods for treating cancer" on Thu, December 12, 2024

Filed a patent for "homologous recombination repair deficiency (hrd) as a predictive biomarker for treating cancer with wee1 inhibitors" on Wed, April 17, 2024

Filed a patent for "combinations" on Thu, May 25, 2023

Filed a patent for "intermittent dosing regimen for zn-c3 in treating cancer" on Tue, November 8, 2022

Filed a patent for "use of ccne1 as a predictive biomarker for treating cancer with wee1 inhibitors" on Tue, November 8, 2022

Filed a patent for "mono- and combination therapies" on Thu, July 6, 2023

Filed a patent for "treatment for amyloidosis" on Thu, July 6, 2023

Filed a patent for "methods of making wee1 inhibitor compounds" on Thu, July 27, 2023

Filed a patent for "salts and forms of a wee1 inhibitor" on Thu, August 24, 2023

Filed a patent for "use of ccne1 as a predictive biomarker for treating cancer with wee1 inhibitors" on Fri, February 17, 2023

Filed a patent for "intermittent dosing regimen for zn-c3 in treating cancer" on Fri, April 14, 2023

Filed a patent for "use of ccne1 as a predictive biomarker for treating cancer with wee1 inhibitors" on Fri, April 14, 2023

Filed a patent for "combinations of bcl-2 inhibitors with chemotherapeutic agents" on Thu, November 30, 2023

Filed a patent for "use of ccne1 as a predictive biomarker for treating cancer with wee1 inhibitors" on Wed, May 24, 2023

Filed a patent for "benzamide compounds" on Fri, May 26, 2023

Filed a patent for "intermittent dosing regimen for zn-c3 in treating cancer" on Fri, June 2, 2023

Filed a patent for "use of ccne1 as a predictive biomarker for treating cancer with wee1 inhibitors" on Fri, June 2, 2023

Filed a patent for "benzamide compounds" on Wed, June 21, 2023

Filed a patent for "benzamide compounds" on Thu, June 6, 2024

Filed a patent for "immunoconjugates and methods" on Thu, March 7, 2024

Filed a patent for "use of ccne1 as a predictive biomarker for treating cancer with wee1 inhibitors" on Thu, October 5, 2023